Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX™ adjuvant in women with cervical intraepithelial neoplasia
Titel:
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX™ adjuvant in women with cervical intraepithelial neoplasia
Auteur:
Frazer, Ian H. Quinn, Michael Nicklin, Jim L. Tan, Jeffrey Perrin, Lew C. Ng, Peng O’Connor, Vivienne M. White, Olivia Wendt, Ngaire Martin, Juliet Crowley, Jayne M. Edwards, Stirling J. McKenzie, Andrew W. Mitchell, Susan V. Maher, Darryl W. Pearse, Martin J. Basser, Russell L.